NEWS

The nuclear medicine industry met in person at the EANM'22 Congress in Barcelona, after 2 years of virtual congresses due to Covid. We truly enjoyed meeting our clients, partners and prospects face-to-face again, and concluded an overall very successful exhibition. We are looking forward to engaging with the industry at next year’s EANM event in Vienna (2023 September).  We will also attend the Arab Health Conference in Dubai from January 30. to February 2, 2023.

Join the team of exceptional professionals and contribute to positive patient outcomes around the world. Medi-Radiopharma is increasing its production capacity in Hungary by building a new plant in order to meet market demands. The expansion consists of two phases, by the end of which the capacity of 3.2 million vials/year will be reached, which is sufficient to cover the entire European market.

Gergely Jánoki CEO of Medi-Radiopharma shares his insights on the activities of the company, the trends in the radiopharmaceutical industry while highlighting regulatory trends, the importance of quality, the driving factors behind the company’s success and his long-term vision of for the company.